XML 43 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information Segment informationThe Company reports segment information based on the internal reporting used by management for making decisions and assessing performance. We manage our business with a focus on two reportable segments. Our Products segment, which includes the Anthrax - MCM products, NARCAN products, Smallpox - MCM products and Other products, and our Services segment consisting of our CDMO services. The Company evaluates the performance of these reportable segments based on revenue and Adjusted Gross Margin, which is a non-GAAP financial measure. Segment revenue includes external customer sales, but it does not include inter-segment services. The Company defines Adjusted Gross Margin as segment revenue less segment cost of sales reduced for significant events, inventory step-up provisions and changes in fair value of contingent consideration. The Company does not allocate research and development, selling, general and administrative costs, amortization of intangibles assets, interest and other income (expense) or taxes to operating segments in the management reporting reviewed by the chief operating decision maker ("CODM"). The accounting policies for segment reporting are the same as for the Company as a whole.
The Company manages its assets on a total company basis, not by operating segment, as the Company's operating assets are shared or commingled. Therefore, the Company's CODM does not regularly review any asset information by operating segment and, accordingly, the Company does not report asset information by operating segment.
The following table includes segment revenues and a reconciliation of the Company's segment adjusted gross margin to the consolidated statement of operations for each of the Company's reporting segments:
Three Months Ended March 31,
20232022
Revenues:
Products$143.4 $237.1 
Services15.2 60.8 
Total segment revenues158.6 297.9 
Contracts and grants revenues6.5 9.6 
Total revenues$165.1 $307.5 
Less: Cost of sales:
Cost of Products$102.9 $80.3 
Cost of Services52.2 75.6 
Total cost of sales$155.1 $155.9 
Products gross margin$40.5 $156.8 
Services gross margin$(37.0)$(14.8)
Consolidated gross margin(1)
$3.5 $142.0 
Adjustments to gross margin:
Products:
Changes in fair value of contingent consideration$1.5 $0.5 
Restructuring costs2.0 — 
Products adjusted gross margin$44.0 $157.3 
Services adjusted gross margin$(37.0)$(14.8)
Consolidated adjusted gross margin(2)
$7.0 $142.5 
Other reconciling items
Contracts and grants revenue$6.5 $9.6 
Adjustments to gross margin(3.5)(0.5)
Research and development(40.6)(46.4)
Selling, general and administrative(100.5)(84.8)
Amortization of intangible assets(17.0)(14.0)
Interest expense(17.9)(8.2)
Other, net4.9 (2.0)
Loss before income taxes$(161.1)$(3.8)
(1) Total segment revenues less total cost of sales.
(2) Consolidated gross margin plus adjustments to gross margin.
The following table includes depreciation expense for each segment:
Three Months Ended March 31,
20232022
Depreciation:
Products$8.0 $7.4 
Services7.9 7.8 
Other1.7 1.4
Total$17.6 $16.6